Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Amgen (AMGN) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareAMGN

Latest price · Nov 20, 2026 $438.92 +0.0% on the day · +34.2% over 12 months 52-week range $307.56 – $478.48
Get AMGN alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling5last 12 months
Reported sales$26.7M0 of 14 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification) and isn't treated as a signal here.

Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Feb 2, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale Rachna Khosla, Svp, Business Development sold 2,000 shares at $412.57 ($825K).

Trade date
Aug 11, 2026
Disclosed to the SEC
Aug 13, 2026
Type
Sale (code S)

Read the original SEC filing ↗All AMGN insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

AMGN insider transactions (Form 4)

Open-market purchases and sales. 115 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Aug 13SEC Rachna KhoslaSvp, Business Development Sell 2,0006,404 held (−24%) $412.57 $825K +6.4% —
Aug 13SEC Rachna KhoslaSvp, Business Development Sell 1,2526,404 held (−16%) $416.43 $521K +5.4% —
Aug 7SEC Derek MillerSvp, Human Resources Sell 2,06912,462 held (−14%) $402.54 $833K +9.0% —
Aug 7SEC Nancy A. GrygielSvp & Cco Sell 1,9707,340 held (−21%) $402.16 $792K +9.1% —
Aug 7SEC Derek MillerSvp, Human Resources Sell 1,82112,462 held (−13%) $402.54 $733K +9.0% —
Aug 7SEC Nancy A. GrygielSvp & Cco Sell 1,0007,340 held (−12%) $402.16 $402K +9.1% —
May 5SEC Nancy A. GrygielSvp & Cco Sell 1,2377,009 held (−15%) $323.73 $400K +35.6% —
Mar 2SEC Esteban SantosEvp, Operations Sell 30,50176,618 held (−28%) $379.12 $11.6M +15.8% —
Mar 2SEC Esteban SantosEvp, Operations Sell 24,29176,618 held (−24%) $379.12 $9.2M +15.8% —
Feb 20SEC Matthew C. BuschVp, Finance & Cao Sell 1,0003,423 held (−23%) $375.79 $376K +16.8% —
Nov 21SEC Nancy A. GrygielSvp & Cco Sell 1,6397,225 held (−18%) $337.26 $553K +30.1% —
Nov 21SEC Nancy A. GrygielSvp & Cco Sell 1,5007,225 held (−17%) $337.26 $506K +30.1% —
Nov 13SEC Murdo GordonEvp, Global Commercial Ops Sell 6,87941,923 held (−14%) $336.83 $2.3M +30.3% —
Nov 13SEC Rachna KhoslaSvp, Business Development Sell 8907,082 held (−11%) $336.24 $299K +30.5% —
Historical context

Similar past setups: not applicable. AMGN has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with AMGN in the Research Lab

AMGN has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

AMGN closeInsider buyInsider sale
300350400450500DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-03EEarnings release filed 2026-04-30EEarnings release filed 2026-08-04EEarnings release filed 2026-11-03Sold $375,790 on 2026-02-19 · Matthew C. BuschSold $400,451 on 2026-05-04 · Nancy A. GrygielSold $521,365 on 2026-08-13 · Rachna KhoslaSold $825,134 on 2026-08-11 · Rachna KhoslaSold $1,058,667 on 2025-11-20 · Nancy A. GrygielSold $2,760,313 on 2026-08-06 · Derek Miller, Nancy A. GrygielSold $20,772,595 on 2026-02-26 · Esteban Santos
Bought, 12 months$0
Sold, 12 months$26.7M
Insiders buying0
Insiders selling5

Amgen insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 5 sold $26.7M of AMGN stock on the open market; P/E 28.5 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

AMGN insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $3.7M sold (4 trades)Q4 2025Q1 2026: $21.1M sold (3 trades)Q1 2026Q2 2026: $400K sold (1 trades)Q2 2026Q3 2026: $4.1M sold (6 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$4.1M6
Q2 2026—0$400K1
Q1 2026—0$21.1M3
Q4 2025—0$3.7M4

Valuation, profit and volume

P/E (trailing)28.5Sector median 25.0
Volume vs. 50-day0.7×Last 5 sessions

Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 Amgen insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $26.7M. 0 of 14 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

AMGN earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Nov 3, 2026 +7.6% None +2.8%S&P +2.0% pending
Aug 4, 2026 +3.4% None +7.6%S&P +1.6% +7.8%
Apr 30, 2026 -3.7% None -2.4%S&P +1.3% +2.9%
Feb 3, 2026 +4.3% None +6.2%S&P -1.3% +1.6%
Nov 4, 2025 -0.8% None +8.0%S&P -0.8% +3.9%
Aug 5, 2025 +2.4% None -5.7%S&P +0.3% +0.4%
May 1, 2025 -1.5% None -3.3%S&P +2.2% +3.4%
Feb 4, 2025 +6.2% None +6.6%S&P +1.1% +6.4%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

AMGN short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 42% of volume sold short2026-08-27: 45% of volume sold short2026-08-28: 41% of volume sold short2026-08-31: 39% of volume sold short2026-09-01: 41% of volume sold short2026-09-02: 54% of volume sold short2026-09-03: 57% of volume sold short2026-09-04: 65% of volume sold short2026-09-08: 62% of volume sold short2026-09-09: 53% of volume sold short2026-09-10: 46% of volume sold short2026-09-11: 41% of volume sold short2026-09-14: 38% of volume sold short2026-09-15: 52% of volume sold short2026-09-16: 55% of volume sold short2026-09-17: 39% of volume sold short2026-09-18: 68% of volume sold short2026-09-21: 58% of volume sold short2026-09-22: 58% of volume sold short2026-09-23: 63% of volume sold short2026-09-24: 65% of volume sold short2026-09-25: 66% of volume sold short2026-09-28: 59% of volume sold short2026-09-29: 72% of volume sold short2026-09-30: 54% of volume sold short2026-10-01: 45% of volume sold short2026-10-02: 35% of volume sold short2026-10-05: 37% of volume sold short2026-10-06: 48% of volume sold short2026-10-07: 63% of volume sold short2026-10-08: 37% of volume sold short2026-10-09: 45% of volume sold short2026-10-12: 62% of volume sold short2026-10-13: 56% of volume sold short2026-10-14: 47% of volume sold short2026-10-15: 44% of volume sold short2026-10-16: 50% of volume sold short2026-10-19: 47% of volume sold short2026-10-20: 63% of volume sold short2026-10-21: 65% of volume sold short2026-10-22: 70% of volume sold short2026-10-23: 43% of volume sold short2026-10-26: 49% of volume sold short2026-10-27: 62% of volume sold short2026-10-28: 70% of volume sold short2026-10-29: 57% of volume sold short2026-10-30: 60% of volume sold short2026-11-02: 40% of volume sold short2026-11-03: 43% of volume sold short2026-11-04: 51% of volume sold short2026-11-05: 50% of volume sold short2026-11-06: 61% of volume sold short2026-11-09: 56% of volume sold short2026-11-10: 62% of volume sold short2026-11-11: 49% of volume sold short2026-11-12: 59% of volume sold short2026-11-13: 49% of volume sold short2026-11-16: 54% of volume sold short2026-11-17: 45% of volume sold short2026-11-18: 52% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 52%20-day average: 54%Prior 2 months: 52%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded AMGN

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Sheldon WhitehouseSenate Sold $15,001 - $50,000 Oct 15, 2026Nov 2, 2026 +1.1%
Sheldon WhitehouseSenate Sold $1,001 - $15,000 Aug 12, 2026Sep 2, 2026 +6.1%
Thomas H TubervilleSenate Sold $15,001 - $50,000 Apr 15, 2025Aug 5, 2026 +55.4%
Alan ArmstrongSenate Sold $15,001 - $50,000 Mar 27, 2026Jul 21, 2026 +27.5%
Sheldon WhitehouseSenate Sold $1,001 - $15,000 Sep 4, 2025Oct 3, 2025 +61.0%

Insiders at Amgen

InsiderBoughtSoldLast filingPast buys beat S&PScore
Esteban SantosEvp, Operations — $20.8M May 11, 2026 — —
Nancy A. GrygielSvp & Cco — $2.7M Aug 7, 2026 — —
Murdo GordonEvp, Global Commercial Ops — $2.3M May 11, 2026 — —
Rachna KhoslaSvp, Business Development — $1.6M Aug 13, 2026 — —
Derek MillerSvp, Human Resources — $1.6M Aug 7, 2026 — —
Matthew C. BuschVp, Finance & Cao — $376K Aug 12, 2026 — —
Michael V. DrakeDirector — — Nov 9, 2026 — —
David W. GibbsDirector — — Nov 9, 2026 — —
Charles M. HolleyDirector — — Nov 9, 2026 — —
Omar IshrakDirector — — Nov 9, 2026 — —
Wanda M. AustinDirector — — May 21, 2026 — —
Brian DrukerDirector — — May 21, 2026 — —
Robert EckertDirector — — May 21, 2026 — —
Greg C. GarlandDirector — — May 21, 2026 — —
Tyler JacksDirector — — May 21, 2026 — —
Mary E. KlotmanDirector — — May 21, 2026 — —
Ellen Jamison KullmanDirector — — May 21, 2026 — —
Amy E. MilesDirector — — May 21, 2026 — —
Robert A. BradwayCEO, President — — May 11, 2026 — —
Peter H. GriffithCFO — — May 11, 2026 — —
David M. ReeseCTO — — May 11, 2026 — —
Jonathan P. GrahamEvp & Gen. Counsel & Sec. — — May 11, 2026 — —
James E. BradnerEvp, Research And Development — — May 11, 2026 — —

Board links: companies that share insiders with AMGN

Directors and executives who filed Form 4s for AMGN and another company in the last 12 months.

See the map →
  • AAPLApple Wanda M. Austin Director here · Director at AAPL · latest filing May 21, 2026
  • CVXChevron Wanda M. Austin Director here · Director at CVX · latest filing May 29, 2026
  • DELLDell Technologies Ellen Jamison Kullman Director here · Director at DELL · latest filing Sep 28, 2026
  • PEPPepsiCo David W. Gibbs Director here · Director at PEP · latest filing Nov 9, 2026
  • PSXPhillips 66 Charles M. Holley Director here · Director at PSX · latest filing Nov 9, 2026
  • TMOThermo Fisher Scientific Tyler Jacks Director here · Director at TMO · latest filing May 22, 2026
  • XOMExxonMobil Greg C. Garland Director here · Director at XOM · latest filing May 21, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

AMGN stock: common questions

Are Amgen insiders buying AMGN stock?

No. No Amgen insider reported an open-market purchase of AMGN in the past 12 months.

Are Amgen insiders selling AMGN stock?

5 insiders reported sales worth $26.7M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is AMGN's P/E ratio?

AMGN trades at about 28.5 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is AMGN's 52-week range?

Over the past year AMGN has traded between $307.56 and $478.48. It last closed at $438.92 on Nov 20, 2026.